欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/2368/001
药品名称
Lipricain
活性成分
lidocaine 2.5 % (W/W)
prilocaine 2.5 % (W/W)
剂型
Cream
上市许可持有人
Teva B.V. Swensweg 5 2031 GA Haarlem Netherlands
参考成员国 - 产品名称
Denmark (DK)
Lipricain
互认成员国 - 产品名称
Netherlands (NL)
Lidocaïne/Prilocaïne Teva 25 + 25 mg/g crème
Italy (IT)
许可日期
2016/01/18
最近更新日期
2023/03/30
药物ATC编码
N01BB20 combinations
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Other Generic application Art 10.3 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Non Prescription (including OTC)
附件文件下载
Final Product Information
|
common_combined_clean 2368 post day 210
Date of last change:2024/09/06
PubAR
|
Final PAR Lidocain_Prilocain Terix cream DKH2368_001_DC
Date of last change:2024/09/06
PubAR Summary
|
Final sPAR Lidocain_Prilocain Terix cream DKH2368_001_DC
Date of last change:2024/09/06
Final PL
|
Lidocaine_Prilocaine_DK_H_2368_PIL_clean
Date of last change:2024/09/06
Final SPC
|
Lidocaine_Prilocaine_DK_H_2368_SmPC_clean
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase